New GAO Report Uncovers Massive Pharmaceutical Fraud
The U.S. Government Accountability Office (GAO) released a report in September 2009 looking at fraud and abuse related to controlled substances paid for by Medicaid.…
Read More »Pharma 101 – Pharmaceutical Fraud
Pharmaceutical Fraud News & Insight form the Qui Tam and False Claims Act Perspective
Contact FormTag Archives: United States
Eli Lilly has Fighting Words for W. Virginia Attorney General
Attorneys representing Eli Lilly & Co. claim that the civil penalties sought by West Virginia Attorney General Darrell McGraw for the pharmaceutical manufacturer's alleged mislabeling…
Read More »Senator Requests Clarification of Recent Memo to FDA Employees
U.S. Sen. Chuck Grassley wrote a letter on March 24, 2009 to FDA's acting commissioner asking for clarification of a recent memo to FDA employees,…
Read More »FDA approves Ranbaxy Laboratories’ drugs despite allegations of fraud and more
FDA has approved 18 products, including generic versions of commonly used cholesterol and allergy medications, by pharmaceutical giant Ranbaxy Laboratories, even though the government has…
Read More »Progress and Deficiencies in the Registration of Clinical Trials
The New England Journal of Medicine just recently published an article which raises questions about the ethics and the science of increasingly conducting studies, or…
Read More »FDA Launches Draft Guidelines On Financial Ties With Drug Companies
If an outside expert has more than $50,000 in ties to drug and medical device companies regulated by the Food and Drug Administration he will…
Read More »Is Big Pharma Manufacturer Roxane Overcharging the Government?
The United States Attorney’s Office announced on January 29, 2007, in Boston, Massachusetts that it is intervening in a whistleblower lawsuit filed against Boehringer Ingelheim…
Read More »Congress now has the power to shake up the FDA
With the new Democratic-controlled Congress, how the FDA accomplishes enforcement will likely change, which may in turn effect the level of resources devoted to the…
Read More »InterMune Pays Nearly $37 Million to Settle Claims for Off Label Marketing
InterMune Inc., a Brisbane, California, biopharmaceutical company, has agreed to pay the government $36.9 million to resolve criminal charges and civil liabilities in connection with…
Read More »Medco Pays Government $155 Million for False Claims
It is pay up time for Medco Health Solutions. The New Jersey based company has settled with the Government in the face of two whistleblower…
Read More »